drugset / Trial / NCT00544934
Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects
RandomizedParallel-groupSingle-blindTreatment
Summary
A dose-ranging study evaluating safety, metabolism and therapeutic dosing of three multiple dose levels of GLY-230 in healthy and diabetic subjects
Timeline
- Start
- 2007-02
- Primary completion
- —
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLY-230 | Other / unclassified | 125 mg | — |
| Subject | GLY-230 | Other / unclassified | 250 mg | — |
| Subject | GLY-230 | Other / unclassified | 375 mg | — |